Blood processing systems and methods using apparent hematocrit as a process control parameter
Abstract
Blood processing systems and methods separate whole blood into red blood cells and a plasma constituent within a rotating centrifugal separation device. The systems and methods convey whole blood into the separation device through an inlet path including a pump operable at a prescribed rate. The systems and methods remove plasma constituent from the separation device through an outlet path including a pump operable at a prescribed rate. The systems and methods derive a value H b representing an apparent hematocrit of whole blood entering the separation device, where: H b = H rbc ( Q b - Q p ) Q b and where H rbc is a value relating to hematocrit of red blood cells in the separation device. The systems and methods generate outputs and control commands based, at least in part, upon H b .
Claims
exact text as granted — not AI-modifiedI claim:
1 . A blood processing system comprising
a centrifugal separation device rotatable at a prescribed rate of rotation, an inlet path including a pump operable at a prescribed rate Q b to convey whole blood into the separation device for separation into red blood cells and a plasma constituent, an outlet path including a pump operable at a prescribed rate Q p to remove plasma constituent from the separation device, an element to derive a value H b representing an apparent hematocrit of whole blood entering the separation device, where:
H b = H rbc ( Q b - Q p ) Q b
and where H rbc is a value relating to hematocrit of red blood cells in the separation device.
2 . A system according to claim 1 and further including an element that generates a control command based, at least in part, upon H b .
3 . A system according to claim 2 wherein the control command recirculates at least a portion of plasma constituent for mixing with whole blood conveyed into the separation device.
4 . A system according to claim 2 wherein the control command controls Q b .
5 . A system according to claim 1 and further including an element that generates an output based, at least in part, upon H b .
6 . A system according to claim 5 wherein the output comprises a value η representing efficiency of separation in the separation device, where:
η = Q p ( 1 - H b ) Q b
7 . A system according to claim 1 wherein the value H rbc represents apparent hematocrit of red blood cells in the separation device, where:
H rbc = 1 - ( β gA κ S γ ( q b - q p ) ) 1 k + 1
where: q b is inlet blood flow rate (cm 3 /sec), which when converted to ml/min, corresponds with Q b , q p is measured plasma flow rate (in cm 3 /sec), which, when converted to ml/min corresponds with Q p , β is a shear rate dependent term, and S Y is a red blood cell sedimentation coefficient (sec) and β/S Y =15.8×10 6 sec −1 , A is the area of the separation device (cm 2 ), g is the centrifugal acceleration (cm/sec 2 ), which is the radius of the separation device multiplied by the rate of rotation squared Ω 2 (rad/sec 2 ), and k is a viscosity constant=0.625, and κ is a viscosity constant based upon k and another viscosity constant α=4.5, where:
κ = k + 2 α [ k + 2 k + 1 ] k + 1 = 1.272
8 . A system according to claim 7 wherein the separation device is free of an sensor to measure blood hematocrit.
9 . A system according to claim 1 wherein the inlet path is free of any sensor to measure blood hematocrit.
10 . A blood processing system comprising
a centrifugal separation device rotatable at a prescribed rate of rotation, an inlet path including a pump operable at a prescribed rate Q b to convey whole blood into the separation device for separation into red blood cells and a plasma constituent, an outlet path including a pump operable at a prescribed rate Q p to remove plasma constituent from the separation device, a recirculation path including a pump operable at a prescribed rate Q Recirc to recirculate at least a portion of the plasma constituent for mixing with whole blood conveyed into the separation device, a controller coupled to the recirculation path pump to set Q Recirc to achieve a desired hematocrit H i for whole blood conveyed into the separation device as follows:
Q Recirc = [ H b H i - 1 ] × Q b
where H b is a value representing an apparent hematocrit of whole blood entering the separation device, where:
H b = H rbc ( Q b - Q p ) Q b
and where H rbc is a value relating to hematocrit of red blood cells in the separation device.
η = Q b ( 1 - H b ) Q b
11 . A system according to claim 10 wherein the value H rbc represents apparent hematocrit of red blood cells in the separation device, where:
H rbc = 1 - ( β gA κ S γ ( q b - q p ) ) 1 k + 1
where: q b is inlet blood flow rate (cm 3 /sec), which when converted to ml/min, corresponds with Q b , q p is measured plasma flow rate (in cm 3 /sec), which, when converted to ml/min corresponds with Q p , β is a shear rate dependent term, and S Y is a red blood cell sedimentation coefficient (sec) and β/S Y =15.8×10 6 sec −1 , A is the area of the separation device (cm 2 ), g is the centrifugal acceleration (cm/sec 2 ), which is the radius of the separation device multiplied by the rate of rotation squared Ω 2 (rad/sec 2 ), and k is a viscosity constant=0.625, and κ is a viscosity constant based upon k and another viscosity constant α=4.5, where:
κ = k + 2 α [ k + 2 k + 1 ] k + 1 = 1.272
12 . A system according to claim 11 wherein the separation device is free of an sensor to measure blood hematocrit.
13 . A system according to claim 10 wherein the inlet path is free of any sensor to measure blood hematocrit.
14 . A system according to claim 10 wherein H i is no greater than about 40%.
15 . A system according to claim 1 wherein H i is about 32%.
16 . A blood processing method comprising the steps of
rotating a centrifugal separation device at a prescribed rate of rotation, conveying whole blood into the separation device at a prescribed rate Q b for separation into red blood cells and a plasma constituent, removing plasma constituent from the separation device at a prescribed rate Q p , deriving a value H b representing an apparent hematocrit of whole blood entering the separation device, where:
H b = H rbc ( Q b - Q p ) Q b
and where H rbc is a value relating to hematocrit of red blood cells in the separation device.
17 . A method according to claim 16 and further including the step of generating a control command based, at least in part, upon H b .
18 . A method according to claim 17 wherein the control command recirculates at least a portion of plasma constituent for mixing with whole blood conveyed into the separation device.
19 . A method according to claim 17 wherein the control command controls Q b .
20 . A method according to claim 16 and further the step of generating an output based, at least in part, upon H b .
21 . A method according to claim 20 wherein the output comprises a value η representing efficiency of separation in the separation device, where:
η = Q b ( 1 - H b ) Q b
22 . A method according to claim 16 wherein the value H rbc represents apparent hematocrit of red blood cells in the separation device, where:
H rbc = 1 - ( β gA κ S γ ( q b - q p ) ) 1 k + 1
where: q b is inlet blood flow rate (cm 3 /sec), which when converted to ml/min, corresponds with Q b , q p is measured plasma flow rate (in cm 3 /sec), which, when converted to ml/min corresponds with Q p , β is a shear rate dependent term, and S Y is a red blood-cell sedimentation coefficient (sec) and β/S Y =15.8×10 6 sec −1 , A is the area of the separation device (cm 2 ), g is the centrifugal acceleration (cm/sec 2 ), which is the radius of the separation device multiplied by the rate of rotation squared Ω 2 (rad/sec 2 ), and k is a viscosity constant=0.625, and κ is a viscosity constant based upon k and another viscosity constant α4.5, where:
κ = k + 2 α [ k + 2 k + 1 ] k + 1 = 1.272
23 . A method according to claim 22 wherein the method is free of a step of using a sensor to measure blood hematocrit in the separation device.
24 . A method according to claim 16 wherein the method is free of a step of using a sensor to measure blood hematocrit in the inlet path.
25 . A blood processing method comprising the steps of
rotating a centrifugal separation device at a prescribed rate of rotation, conveying whole blood into the separation device at a prescribed rate Q b for separation into red blood cells and a plasma constituent, removing plasma constituent from the separation device at a prescribed rate Q p , recirculating at least a portion of plasma constituent from the separation device at a prescribed rate Q Recirc for mixing with whole blood conveyed into the separation device, controlling Q Recirc to achieve a desired hematocrit H i for whole blood conveyed into the separation device as follows:
Q Recirc = [ H b H i - 1 ] × Q b
recirculating at least a portion of plasma constituent from the separation device at a prescribed rate Q Recirc for mixing with whole blood conveyed into the separation device, controlling Q Recirc to achieve a desired hematocrit H i for whole blood conveyed into the separation device as follows:
Q Recirc = [ H b H i - 1 ] × Q b
where H b is a value representing an apparent hematocrit of whole blood entering the separation device, where:
H b = H rbc ( Q b - Q p ) Q b
and where H rbc is a value relating to hematocrit of red blood cells in the separation device.
26 . A method according to claim 25 wherein the value H rbc represents apparent hematocrit of red blood cells in the separation device, where:
H rbc = 1 - ( β gA κ S γ ( q b - q b ) ) 1 k + 1
where: q b is inlet blood flow rate (cm 3 /sec), which when converted to ml/min, corresponds with Q b , q p is measured plasma flow rate (in cm 3 /sec), which, when converted to ml/min corresponds with Q p , β is a shear rate dependent term, and S Y is a red blood cell sedimentation coefficient (sec) and β/S Y =15.8×10 6 sec −1 , A is the area of the separation device (cm 2 ), g is the centrifugal acceleration (cm/sec 2 ), which is the radius of the separation device multiplied by the rate of rotation squared Ω 2 (rad/sec 2 ), and k is a viscosity constant=0.625, and κ is a viscosity constant based upon k and another viscosity constant α=4.5, where:
κ = k + 2 α [ k + 2 k + 1 ] k + 1 = 1.272
27 . A method according to claim 26 wherein the method is free of a step of using a sensor to measure blood hematocrit in the separation device.
28 . A method according to claim 25 wherein the method is free of a step of using a sensor to measure blood hematocrit in the inlet path.Join the waitlist — get patent alerts
Track US2001008221A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.